244 related articles for article (PubMed ID: 7944478)
21. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
22. [Property of scirrhous carcinoma of the stomach defined by collagen metabolism].
Niitsu Y; Ito N; Owada M; Morita K; Matsuura K; Kohgo Y; Urushizaki I
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1229-35. PubMed ID: 2837982
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between urokinase-type plasminogen activator expression and peritoneal metastatic potency in different gastric cancer cell lines].
Ding YC; Zhu ZG; Liu BY; Ji YB; Chen XH; Zhang Y; Yu YY; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):249-51. PubMed ID: 16167240
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological study of diffuse carcinoma of stomach (author's transl)].
Shimoda T
Hokkaido Igaku Zasshi; 1978 Nov; 52(6):305-25. PubMed ID: 204562
[TBL] [Abstract][Full Text] [Related]
27. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
28. Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma.
Yashiro M; Chung YS; Sowa M
Jpn J Cancer Res; 1994 Sep; 85(9):883-6. PubMed ID: 7961114
[TBL] [Abstract][Full Text] [Related]
29. [Pathology and histogenesis of gastric scirrhous carcinoma].
Kino I
Gan No Rinsho; 1984 May; 30(6 Suppl):703-9. PubMed ID: 6086972
[TBL] [Abstract][Full Text] [Related]
30. ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion.
Yagi R; Tanaka M; Sasaki K; Kamata R; Nakanishi Y; Kanai Y; Sakai R
Oncogene; 2011 Mar; 30(12):1413-21. PubMed ID: 21076469
[TBL] [Abstract][Full Text] [Related]
31. [Mechanisms responsible for the progression of scirrhous gastric cancer].
Yashiro M; Ohira M; Muguruma K; Shinto O; Hirakawa K
Nihon Rinsho; 2012 Oct; 70(10):1812-6. PubMed ID: 23198567
[TBL] [Abstract][Full Text] [Related]
32. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
[TBL] [Abstract][Full Text] [Related]
33. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction.
Nakajima K; Okita Y; Matsuda S
Oncol Rep; 2004 Jul; 12(1):85-90. PubMed ID: 15201964
[TBL] [Abstract][Full Text] [Related]
35. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells.
Ragno P; Montuori N; Covelli B; Hoyer-Hansen G; Rossi G
Cancer Res; 1998 Mar; 58(6):1315-9. PubMed ID: 9515821
[TBL] [Abstract][Full Text] [Related]
37. [uPA expression of gastric cancer cell lines and its correlation with peritoneal seeding].
Ding YC; Zhu ZG; Liu BY; Ji YB; Chen XH; Zhang Y; Yu YY; Lin YZ
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):13-5. PubMed ID: 15771790
[TBL] [Abstract][Full Text] [Related]
38. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer.
Jin H; Pan Y; He L; Zhai H; Li X; Zhao L; Sun L; Liu J; Hong L; Song J; Xie H; Gao J; Han S; Li Y; Fan D
Mol Cancer Res; 2007 May; 5(5):423-33. PubMed ID: 17510309
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
40. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
